![](/media/images/versions/img94joktmu729754.png)
New drug for aggressive breast cancer could save thousands of lives
An immunotherapy drug called ‘pembrolizumab’ has been shown to significantly reduce disease recurrence in patients with the most aggressive type of breast cancer, according to results from a phase III clinical trial led.